Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

147.97 +1.59 (+1.09%)
Official Closing Price Updated: 4:10 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,224,205
Open 147.64
Bid (Size) 147.33 (20)
Ask (Size) 148.24 (1)
Prev. Close 146.38
Today's Range 145.20 - 148.38
52wk Range 130.96 - 168.11
Shares Outstanding N/A
Dividend Yield 4.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Healthcare Gems: 3 Essential Long-Term Stock Picks
Global healthcare spending reached a record $9 trillion in 2020. Catch the ongoing benefits with these three long-term healthcare stock picks. 
Via InvestorPlace
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
Wednesday, AbbVie Inc (NYSE: ABBV) agreed to acquire Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) for a total equity value of approximately $8.7 billion, or $45 per share in cash, with the... 
Via Benzinga

Performance

YTD
-8.87%
-8.87%
1 Month
+4.79%
+4.79%
3 Month
+1.62%
+1.62%
6 Month
+8.89%
+8.89%
1 Year
-9.62%
-9.62%

More News

Read More
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Is AbbVie Stock a Buy Now?
Via The Motley Fool
Decoding AbbVie's Options Activity: What's the Big Picture?
Via Benzinga
Analyst Ratings for AbbVie
Via Benzinga
Why Cerevel Therapeutics Stock Is Higher
Via Benzinga
Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?
Via InvestorPlace
Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
Via The Motley Fool
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.
Via The Motley Fool
Why Cerevel Therapeutics Holdings Is Moving After-Hours
Via Benzinga
7 High-Dividend Stocks to Buy for a Lifetime of Passive Income
Via InvestorPlace
Small Cap, Big Potential: 3 Russell 2000 Stocks to Watch
Via InvestorPlace
3 Stocks at the Forefront of Personalized Medicine Trend
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hawaiian Holdings, Inc. (Nasdaq – HA), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
From Brodsky & Smith LLC
Via GlobeNewswire
ImmunoGen, AbbVie's $10B Deal Comes At 'Right Time' Analyst Says In Downgrade Note
Via Benzinga
AbbVie's Big Buy Of ImmunoGen Opens Doors For Potential Investment Gains
Via Talk Markets
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Via MarketBeat
Topics Bonds
Exposures Debt Markets
2 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
5 S&P 500 Stocks That Pay a Generous Dividend
Via The Motley Fool
Topics Stocks
Exposures US Equities
Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
These biotechs targeting multiple neurodegenerative diseases
Via MarketBeat
ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.